A 2 Step Approach to Myeloablative Haploidentical Hematopoietic Stem Cell Transplanation (HSCT): Report of a Phase II Trial With 18 Months of Follow-Up for All Patients

Publication/Presentation Date

2-2011

Volume

17

Issue

2

First Page

171

Last Page

171

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article

Share

COinS